Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as an experimental model of cerebral ischemia

Cerebrovascular Diseases

Volumn 37, Issue 3, 2014, Pages 171-180

  Sun, Ping ^a   Solé, Montse ^a   Unzeta, Mercedes ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Adhesion proteins; Endothelial cells; Metalloproteinase activity; SSAO; Stroke; VAP 1; Vascular damage

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); BATIMASTAT; CASPASE 3; CASPASE 8; GELATINASE A; GLUCOSE; METHYLAMINE; OXYGEN; VASCULAR ADHESION PROTEIN 1; CASPASE 12; LACTATE DEHYDROGENASE; METALLOPROTEINASE INHIBITOR; PROTEIN BAX; PROTEIN BCL 2; TISSUE PLASMINOGEN ACTIVATOR;

APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CELL DAMAGE; CELL MEMBRANE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME SUBSTRATE; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REOXYGENATION; TISSUE INJURY; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; BINDING AFFINITY; BLOOD VESSEL INJURY; BRAIN HEMORRHAGE; CATALYSIS; CELL INFILTRATION; CELL LYSATE; CELL VIABILITY; DISEASE COURSE; ENDOTHELIUM CELL; INFLAMMATION; OXIDATION;

AMINE OXIDASE (COPPER-CONTAINING); APOPTOSIS; BRAIN ISCHEMIA; CELL ADHESION; CELL ADHESION MOLECULES; CELL HYPOXIA; CELL SURVIVAL; ENDOTHELIAL CELLS; GLUCOSE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LEUKOCYTE ROLLING; MATRIX METALLOPROTEINASE 2; METHYLAMINES; OXYGEN; PHENELZINE; RECOMBINANT FUSION PROTEINS; SEMICARBAZIDES; TRANSFECTION;

EID: 84893648725     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000357660     Document Type: Article

References (42)

1. Woodruff TM, Thundyil J, Tang SC, Sobey CG, Taylor SM, Arumugam TV: Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener 2011; 6: 11-29.
2. DiNapoli VA, Huber JD, Houser K, Li X, Rosen CL: Early disruptions of the bloodbrain barrier may contribute to exacerbated neuronal damage and prolonged functional recovery following stroke in aged rats. Neurobiol Aging 2008; 29: 753-764.
3. Iadecola C, Anrather J: The immunology of stroke: from mechanisms to translation. Nat Med 2011; 17: 796-808.
4. Jalkanen S, Salmi M: VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. Arterioscler Thromb Vasc Biol 2008; 28: 18-26.
5. Smith DJ, Salmi M, Bono P, Hellman J, Leu T, Jalkanen S: Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med 1998; 188: 17-27.
6. OSullivan J, Unzeta M, Healy J, OSullivan MI, Davey G, Tipton KF: Semicarbazide-sensitive amine oxidases: enzymes with quite a lot to do. Neurotoxicology 2004; 25: 303-315.
7. Yu PH, Deng YL: Endogenous formaldehyde as a potential factor of vulnerability of atherosclerosis: involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover. Atherosclerosis 1998; 140: 357-363.
8. Boomsma F, Derkx FH, van den Meiracker AH, Man in t Veld AJ, Schalekamp MA: Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin Sci (Lond) 1995; 88: 675-679.
9. Boomsma F, van Veldhuisen DJ, de Kam PJ, Man in t Veld AJ, Mosterd A, Lie KI, Schalekamp MA: Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc Res 1997; 33: 387-391.
10. Meszaros Z, Karadi I, Csanyi A, Szombathy T, Romics L, Magyar K: Determination of human serum semicarbazide-sensitive amine oxidase activity: a possible clinical marker of atherosclerosis. Eur J Drug Metab Pharmacokinet 1999; 24: 299-302.
11. Kurkijarvi R, Adams DH, Leino R, Mottonen T, Jalkanen S, Salmi M: Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J Immunol 1998; 161: 1549-1557.
12. Madej A, Reich A, Orda A, Szepietowski JC: Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients. J Eur Acad Dermatol Venereol 2007; 21: 72-78.
13. del Mar Hernandez M, Esteban M, Szabo P, Boada M, Unzeta M: Human plasma semicarbazide sensitive amine oxidase (SSAO), ?-amyloid protein and aging. Neurosci Lett 2005; 384: 183-187.
14. Ferrer I, Lizcano JM, Hernandez M, Unzeta M: Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimers disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Neurosci Lett 2002; 321: 21-24.
15. Airas L, Lindsberg PJ, Karjalainen-Lindsberg ML, Mononen I, Kotisaari K, Smith DJ, Jalkanen S: Vascular adhesion protein-1 in human ischaemic stroke. Neuropathol Appl Neurobiol 2008; 34: 394-402.
16. Conklin DJ, Langford SD, Boor PJ: Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity. Toxicol Sci 1998; 46: 386-392.
17. Hernandez M, Sole M, Boada M, Unzeta M: Soluble semicarbazide sensitive amine oxidase (SSAO) catalysis induces apoptosis in vascular smooth muscle cells. Biochim Biophys Acta 2006; 1763: 164-173.
18. Sole M, Hernandez-Guillamon M, Boada M, Unzeta M: p53 phosphorylation is involved in vascular cell death induced by the catalytic activity of membrane-bound SSAO/VAP-1. Biochim Biophys Acta 2008; 1783: 1085-1094.
19. Hernandez-Guillamon M, Garcia-Bonilla L, Sole M, Sosti V, Pares M, Campos M, Ortega-Aznar A, Dominguez C, Rubiera M, Ribo M, Quintana M, Molina CA, Alvarez-Sabin J, Rosell A, Unzeta M, Montaner J: Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke. Stroke 2010; 41: 1528-1535.
20. Hernandez-Guillamon M, Sole M, Delgado P, Garcia-Bonilla L, Giralt D, Boada C, Penalba A, Garcia S, Flores A, Ribo M, Alvarez-Sabin J, Ortega-Aznar A, Unzeta M, Montaner J: VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke. Cerebrovasc Dis 2012; 33: 55-63.
21. Sole M, Hernandez M, Boada M, Unzeta M: Characterization of A7r5 cell line transfected in a stable form by hSSAO/VAP-1 gene (A7r5 hSSAO/VAP-1 cell line). J Neural Transm 2007; 114: 763-767.
22. Sole M, Unzeta M: Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases. Biol Cell 2011; 103: 543-557.
23. Plumb JA, Milroy R, Kaye SB: Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromideformazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res 1989; 49: 4435-4440.
24. Otsuka S, Kobayashi Y: Radioisotopic assay for monoamine oxidase determinations in human plasma. Biochem Pharmacol 1964; 13: 995-1006.
25. Candelario-Jalil E, Yang Y, Rosenberg GA: Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 2009; 158: 983-994.
26. Hernandez-Guillamon M, Martinez-Saez E, Delgado P, Domingues-Montanari S, Boada C, Penalba A, Boada M, Pagola J, Maisterra O, Rodriguez-Luna D, Molina CA, Rovira A, Alvarez-Sabin J, Ortega-Aznar A, Montaner J: MMP-2/MMP-9 plasma level and brain expression in cerebral amyloid angiopathy-associated hemorrhagic stroke. Brain Pathol 2012; 22: 133-141.
27. Reuter B, Rodemer C, Grudzenski S, Couraud PE, Weksler B, Romero IA, Meairs S, Bugert P, Hennerici MG, Fatar M: Temporal profile of matrix metalloproteinases and their inhibitors in a human endothelial cell culture model of cerebral ischemia. Cerebrovasc Dis 2013; 35: 514-520.
28. Abella A, Garcia-Vicente S, Viguerie N, Ros-Baro A, Camps M, Palacin M, Zorzano A, Marti L: Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner. Diabetologia 2004; 47: 429-438.
29. Rubino MT, Agamennone M, Campestre C, Campiglia P, Cremasco V, Faccio R, Laghezza A, Loiodice F, Maggi D, Panza E, Rossello A, Tortorella P: Biphenyl sulfonylamino methyl bisphosphonic acids as inhibitors of matrix metalloproteinases and bone resorption. Chem Med Chem 2011; 6: 1258-1268.
30. Rosell A, Cuadrado E, Ortega-Aznar A, Hernandez-Guillamon M, Lo EH, Montaner J: MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke 2008; 39: 1121-1126.
31. Koskinen K, Vainio PJ, Smith DJ, Philavisto M, Yla-Herttuala S, Jalkanen S, Salmi M: Granulocyte transmigration through the endothelium is regulated by the oxidase activity of the vascular adhesion protein-1 (VAP-1). Blood 2004; 103: 3388-3395.
32. Smeraldi C, Castillo V, Lizcano JM, Unzeta M: Some properties of semicarbazide-sensitive amine oxidase (SSAO) from human cerebrovascular tissues. Inflamm Res 2001; 50:S144-S145.
33. Castillo V, Lizcano JM, Unzeta M: Presence of SSAO in human and bovine meninges and microvessels. Neurobiology (Bp) 1999; 7: 263-272.
34. Castillo V, Lizcano JM, Visa J, Unzeta M: Semicarbazide-sensitive amine oxidase (SSAO) from human and bovine cerebrovascular tissues: biochemical and immunohistological characterization. Neurochem Int 1998; 33: 415-423.
35. Stolen CM, Marttila-Ichihara F, Koskinen K, Yegutkin GG, Turja R, Bono P, Skurnik M, Hanninen A, Jalkanen S, Salmi M: Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo. Immunity 2005; 22: 105-115.
36. Stolen CM, Yegutkin GG, Kurkijarvi R, Bono P, Alitalo K, Jalkanen S: Origins of serum semicarbazide-sensitive amine oxidase. Circ Res 2004; 95: 50-57.
37. Pradeep H, Diya JB, Shashikumar S, Rajanikant GK: Oxidative stress: assassin behind the ischemic stroke. Folia Neuropathol 2012; 50: 219-230.
38. Manzanero S, Santro T, Arumugam TV: Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury. Neurochem Int 2013; 62: 712-718.
39. Unzeta M, Sole M, Boada M, Hernandez M: Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimers disease. J Neural Transm 2007; 114: 857-862.
40. Morancho A, Rosell A, Garcia-Bonilla L, Montaner J: Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? Ann NY Acad Sci 2010; 1207: 123-133.
41. Frijns CJ, Kappelle LJ: Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 2002; 33: 2115-2122.
42. Jalkanen S, Karikoski M, Mercier N, Koskinen K, Henttinen T, Elima K, Salmivirta K, Salmi M: The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E-and P-selectins and leukocyte binding. Blood 2007; 110: 1864-1870.